Second-line endocrine management: anti-androgens and anti-estrogens.
D000726:Androgen Antagonists / Q000627:therapeutic use*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013629:Tamoxifen / Q000627:therapeutic use
D000726:Androgen Antagonists; D004965:Estrogen Antagonists; D013629:Tamoxifen